End-of-day quote
Shanghai S.E.
18:00:00 2024-05-08 EDT
|
5-day change
|
1st Jan Change
|
19.34
CNY
|
+2.06%
|
|
+0.94%
|
-5.75%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,990
|
11,957
|
6,909
|
8,300
|
7,823
|
-
|
Enterprise Value (EV)
1 |
6,990
|
11,957
|
6,909
|
8,300
|
7,823
|
7,823
|
P/E ratio
|
25
x
|
37.9
x
|
19
x
|
20.3
x
|
15.2
x
|
12.6
x
|
Yield
|
-
|
1.18%
|
2.34%
|
2.19%
|
2.64%
|
3.21%
|
Capitalization / Revenue
|
-
|
3.51
x
|
1.82
x
|
1.99
x
|
1.45
x
|
1.24
x
|
EV / Revenue
|
-
|
3.51
x
|
1.82
x
|
1.99
x
|
1.45
x
|
1.24
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-313
x
|
13.2
x
|
52.9
x
|
60.2
x
|
14.4
x
|
FCF Yield
|
-
|
-0.32%
|
7.58%
|
1.89%
|
1.66%
|
6.93%
|
Price to Book
|
-
|
4.89
x
|
2.6
x
|
2.85
x
|
2.24
x
|
2.03
x
|
Nbr of stocks (in thousands)
|
404,500
|
404,500
|
404,500
|
404,500
|
404,500
|
-
|
Reference price
2 |
17.28
|
29.56
|
17.08
|
20.52
|
19.34
|
19.34
|
Announcement Date
|
21-02-26
|
22-02-23
|
23-02-07
|
24-01-26
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
3,407
|
3,795
|
4,173
|
5,381
|
6,325
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
346.3
|
380.5
|
454.3
|
553
|
665
|
Operating Margin
|
-
|
10.16%
|
10.03%
|
10.89%
|
10.28%
|
10.51%
|
Earnings before Tax (EBT)
1 |
-
|
351.9
|
382.1
|
453.9
|
556
|
668
|
Net income
1 |
281
|
315.1
|
363.3
|
410.1
|
516
|
625
|
Net margin
|
-
|
9.25%
|
9.57%
|
9.83%
|
9.59%
|
9.88%
|
EPS
2 |
0.6900
|
0.7800
|
0.9000
|
1.010
|
1.270
|
1.540
|
Free Cash Flow
1 |
-
|
-38.21
|
523.7
|
157
|
130
|
542
|
FCF margin
|
-
|
-1.12%
|
13.8%
|
3.76%
|
2.42%
|
8.57%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
144.14%
|
38.29%
|
25.19%
|
86.72%
|
Dividend per Share
2 |
-
|
0.3500
|
0.4000
|
0.4500
|
0.5100
|
0.6200
|
Announcement Date
|
21-02-26
|
22-02-23
|
23-02-07
|
24-01-26
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-38.2
|
524
|
157
|
130
|
542
|
ROE (net income / shareholders' equity)
|
-
|
13.3%
|
14.3%
|
14.8%
|
14.8%
|
16.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
6.040
|
6.580
|
7.210
|
8.620
|
9.550
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
146
|
182
|
243
|
165
|
171
|
Capex / Sales
|
-
|
4.29%
|
4.79%
|
5.82%
|
3.07%
|
2.7%
|
Announcement Date
|
21-02-26
|
22-02-23
|
23-02-07
|
24-01-26
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -5.75% | 1.08B | | 0.00% | 7.31B | | -10.21% | 2.96B | | -9.02% | 2.79B | | -28.49% | 1.81B | | +4.06% | 1.24B | | -9.64% | 845M | | -8.98% | 813M | | -3.23% | 802M | | +0.21% | 759M |
Testing Laboratories
|